Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

6.31
Delayed Data
As of May 27
 -0.23 / -3.52%
Today’s Change
5.02
Today|||52-Week Range
13.00
-20.13%
Year-to-Date
Merrimack/Baxalta Start Study on Colorectal Cancer Drug
May 20 / Zacks.com - Paid Partner Content